Open AccessDiet therapy in patients with metabolically associated fatty liver disease: what is the choice for particular patient?
Author(s) -
Е. А. Lyalyukova,
И. В. Друк,
И. В. Долгалев,
Е. Н. Чернышева,
Е. Н. Логинова,
Г. М. Коновалова
Publication year - 2021
Publication title -
èksperimentalʹnaâ i kliničeskaâ gastroènterologiâ
Language(s) - English
Resource type - Journals
ISSN - 1682-8658
DOI - 10.31146/1682-8658-ecg-194-10-109-117
Subject(s) - medicine , disease , fatty liver , obesity , mediterranean diet , glycemic , glycemic index , insulin
Metabolically associated fatty liver disease is a widespread disease (MAFLD). The main treatment strategy for MAFLD is the correction of metabolic factors, changes in lifestyle, normalization of body weight, which is achieved by the use of diet therapy and physical activity. The purpose of this review is to present the characteristics of diets that have been studied in the treatment of patients with MAFLD. Results . The greatest evidence base on the effectiveness of treatment of MAFLD and the safety profile is the use of the Mediterranean diet and the diet with a low glycemic index. Patients should be advised to reduce their sugar intake, reduce their intake of saturated fatty acids and trans fats, and increase their intake of dietary fiber. Eating a balanced, calorie-restricted diet can help to provide healthy lifestyle and healthy eating habits, which are essential for the prevention and treatment of MAFLD. Hereditary factors, the composition of the intestinal microbiota, comorbid pathology can affect the results of diet therapy, which emphasizes the urgent need for an individualized approach in the treatment of this disease.